XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 689 $ 21,779,340 $ (14,239,075) $ 7,540,954
Balance, shares at Dec. 31, 2020 6,891,608      
Changes in Stockholders' Equity        
Exercise of stock options $ 1 3,016   3,017
Exercise of stock options, shares 3,868      
Cashless exercise of warrants $ 5 (5)    
Cashless exercise of warrants, shares 51,644      
Stock-based compensation expense   23,977   23,977
Net loss     (3,199,673) (3,199,673)
Balance at Mar. 31, 2021 $ 695 21,806,328 (17,438,748) 4,368,275
Balance, shares at Mar. 31, 2021 6,947,120      
Balance at Dec. 31, 2020 $ 689 21,779,340 (14,239,075) 7,540,954
Balance, shares at Dec. 31, 2020 6,891,608      
Changes in Stockholders' Equity        
Net loss       (8,572,491)
Balance at Sep. 30, 2021 $ 810 69,340,645 (22,811,566) 46,529,889
Balance, shares at Sep. 30, 2021 8,100,570      
Balance at Mar. 31, 2021 $ 695 21,806,328 (17,438,748) 4,368,275
Balance, shares at Mar. 31, 2021 6,947,120      
Changes in Stockholders' Equity        
Issuance of common stock, net of issuance costs $ 100 46,668,313   46,668,413
Issuance of common stock, net of issuance costs (in shares) 1,000,000      
Exercise of stock options $ 14 92,071   92,085
Exercise of stock options, shares 141,532      
Cashless exercise of warrants, shares 2,280      
Stock-based compensation expense   7,992   7,992
Net loss     (2,524,602) (2,524,602)
Balance at Jun. 30, 2021 $ 809 68,574,704 (19,963,350) 48,612,163
Balance, shares at Jun. 30, 2021 8,090,932      
Changes in Stockholders' Equity        
Issuance costs   (20,000)   (20,000)
Exercise of stock options $ 1 (1)    
Exercise of stock options, shares 9,638      
Stock-based compensation expense   785,942   785,942
Net loss     (2,848,216) (2,848,216)
Balance at Sep. 30, 2021 $ 810 69,340,645 (22,811,566) 46,529,889
Balance, shares at Sep. 30, 2021 8,100,570      
Balance at Dec. 31, 2021 $ 810 73,220,361 (28,726,207) 44,494,964
Balance, shares at Dec. 31, 2021 8,100,570      
Changes in Stockholders' Equity        
Exercise of stock options $ 6 4,607   4,613
Exercise of stock options, shares 63,353      
Stock-based compensation expense   3,434,944   3,434,944
Net loss     (5,894,213) (5,894,213)
Balance at Mar. 31, 2022 $ 816 76,659,912 (34,620,420) 42,040,308
Balance, shares at Mar. 31, 2022 8,163,923      
Balance at Dec. 31, 2021 $ 810 73,220,361 (28,726,207) 44,494,964
Balance, shares at Dec. 31, 2021 8,100,570      
Changes in Stockholders' Equity        
Net loss       (22,233,790)
Balance at Sep. 30, 2022 $ 816 80,919,684 (50,959,997) 29,960,503
Balance, shares at Sep. 30, 2022 8,163,923      
Balance at Mar. 31, 2022 $ 816 76,659,912 (34,620,420) 42,040,308
Balance, shares at Mar. 31, 2022 8,163,923      
Changes in Stockholders' Equity        
Stock-based compensation expense   1,903,761   1,903,761
Net loss     (8,718,131) (8,718,131)
Balance at Jun. 30, 2022 $ 816 78,563,673 (43,338,551) 35,225,938
Balance, shares at Jun. 30, 2022 8,163,923      
Changes in Stockholders' Equity        
Stock-based compensation expense   2,356,011   2,356,011
Net loss     (7,621,446) (7,621,446)
Balance at Sep. 30, 2022 $ 816 $ 80,919,684 $ (50,959,997) $ 29,960,503
Balance, shares at Sep. 30, 2022 8,163,923